Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgery

被引:13
|
作者
Wildfeuer, A
Mallwitz, J
Gotthardt, H
Hille, E
Gruber, H
Dahmen, G
Pfaff, G
Gobel, C
机构
[1] ALLGEMEINES KRANKENHAUS,D-22307 HAMBURG,GERMANY
[2] UNIV EPPENDORF,ORTHOPAD KLIN,D-20251 HAMBURG,GERMANY
[3] PFIZER GMBH,KLIN FORSCH,D-76032 KARLSRUHE,GERMANY
关键词
D O I
10.1007/BF01713160
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
As perioperative prophylaxis for major orthopedic operations 81 patients were given the fixed combination of ampicillin (1 g)/sulbactam (0.5 g) or cefotiam (2 g) as short infusions, The three beta-lactams were rapidly distributed into the different tissues and their pharmacokinetic profiles were found to be very similar It was noteworthy that ampicillin, sulbactam and cefotiam penetrated within minutes, not only into skin, fat and muscles, but also into bone, Thus 0.25 h after starting the infusion the following mean concentrations were measured in bone: 21.8 +/- 10.5 mg/kg ampicillin, 4.9 +/- 2.2 mg/kg sulbactam and 19.4 +/- 10.6 mg/kg cefotiam, For a period of at least 2 h the concentrations measured in serum and in the different tissues affected by the operation (skin, fat, muscle, bone) were above the MICs for pathogens which are involved in postoperative wound infections, On the basis of pharmacokinetic data, ampicillin/sulbactam and cefotiam seem about equally suitable for perioperative prophylaxis in major orthopedic operations.
引用
收藏
页码:258 / 262
页数:5
相关论文
共 50 条
  • [1] Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgery
    A. Wildfeuer
    J. Mallwitz
    H. Gotthardt
    E. Hille
    H. Gruber
    G. Dahmen
    G. Pfaff
    G. Göbel
    Infection, 1997, 25 : 258 - 262
  • [2] PHARMACOKINETICS OF AMPICILLIN AND SULBACTAM IN PATIENTS UNDERGOING HEART-SURGERY
    WILDFEUER, A
    MULLER, V
    SPRINGSKLEE, M
    SONNTAG, HG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) : 1772 - 1776
  • [3] Pharmacokinetics of ampicillin/sulbactam in patients undergoing spinal microneurosurgical procedures
    Warnke, JP
    Wildfeuer, A
    Eibel, G
    Pfaff, G
    Klammer, A
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1998, 36 (05) : 253 - 257
  • [4] Pharmacokinetics of Prophylactic Ampicillin Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass
    Yokoyama, Yuta
    Matsumoto, Kazuaki
    Ikawa, Kazuro
    Watanabe, Erika
    Yamamoto, Hiroyuki
    Imoto, Yutaka
    Morikawa, Norifumi
    Takeda, Yasuo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (11) : 1817 - 1821
  • [5] Pharmacokinetics of ampicillin and sulbactam in pediatric patients
    Nahata, MC
    Vashi, VI
    Swanson, RN
    Messig, MA
    Chung, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) : 1225 - 1229
  • [6] Pharmacokinetics of Ampicillin/Sulbactam in patients with acute kidney injury undergoing extended dialysis
    Lorenzen, J.
    Kaever, V
    Broll, M.
    Burkhardt, O.
    Kielstein, J. T.
    INFECTION, 2009, 37 : 55 - 55
  • [7] CONCENTRATIONS OF AMPICILLIN AND SULBACTAM IN SERUM AND TISSUES OF PATIENTS UNDERGOING ENT SURGERY
    WILDFEUER, A
    LUCKHAUPT, H
    SPRINGSKLEE, M
    INFECTION, 1991, 19 (01) : 58 - 60
  • [8] Pharmacokinetics of ampicillin sulbactam in patients undergoing colorectal surgery: Measurements in serum, the colonic wall and in tissue at the incision site
    Wenzel, M
    Wildfeuer, A
    Gutsche, F
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1996, 6 : S35 - S39
  • [9] PHARMACOKINETICS OF AMPICILLIN AND SULBACTAM IN PREGNANCY
    CHAMBERLAIN, A
    WHITE, S
    BAWDON, R
    THOMAS, S
    LARSEN, B
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (02) : 667 - 673
  • [10] The pharmacokinetics of ampicillin–sulbactam in anuric patients: dosing optimization for prophylaxis during cardiovascular surgery
    Yuta Yokoyama
    Kazuaki Matsumoto
    Kazuro Ikawa
    Erika Watanabe
    Hiroyuki Yamamoto
    Yutaka Imoto
    Norifumi Morikawa
    Yasuo Takeda
    International Journal of Clinical Pharmacy, 2016, 38 : 771 - 775